Asymchem Laboratories (Tianjin) Co., Ltd. (SHE:002821)

China flag China · Delayed Price · Currency is CNY
79.98
-0.36 (-0.45%)
Mar 28, 2025, 2:44 PM CST
-10.55%
Market Cap 27.53B
Revenue (ttm) 5.80B
Net Income (ttm) 948.95M
Shares Out 354.88M
EPS (ttm) 2.69
PE Ratio 29.61
Forward PE 26.47
Dividend 1.80 (2.26%)
Ex-Dividend Date Jun 28, 2024
Volume 3,457,882
Average Volume 3,268,564
Open 80.00
Previous Close 80.34
Day's Range 79.80 - 82.76
52-Week Range 59.55 - 94.28
Beta 0.26
RSI 50.22
Earnings Date Mar 29, 2025

About SHE:002821

Asymchem Laboratories (Tianjin) Co., Ltd. provides clinical stage CDMO, commercial stage CDMO, and emerging services in Mainland China and internationally. The company offers process development and optimization, analytical, and scale-up services for small molecule drug products throughout the pre-clinical and clinical stage; and ton-scale manufacturing services for registered starting materials, advanced intermediates, and active pharmaceutical ingredients. It also engages in pre-formulation and formulation development; provision of chemical m... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1998
Employees 9,788
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002821
Full Company Profile

Financial Performance

In 2024, SHE:002821's revenue was 5.80 billion, a decrease of -25.82% compared to the previous year's 7.83 billion. Earnings were 948.95 million, a decrease of -58.17%.

Financial Statements

News

There is no news available yet.